Tremacamra

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTremacamra
Drug Alias NameBIRR 4sICAMsICAM-rhinovirussoluble ICAM-1BIRR-004 +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRhinovirus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRhinovirus infection

Other Information

ATC CodeN/A
Related LinksWikipedia